NCT06248398

Brief Summary

The purpose of this study is to compare two methods of cochlear implantation : conventional manual insertion versus robot-assisted in order to verify whether robotic insertion provides better performance in the noisy environment. To do this, we will compare the two methods of insertion of the electrode holder, on 140 patients candidates for cochlear implantation randomized in two groups (70 conventional surgery versus 70 robot-assisted surgery). All patients will be recruited during 17 months, in our Ear, nose and throat (ENT) Department of the Pitié-Salpêtrière hospital group, the first center for adult patients established in France (on average 180 patients/year). Patient will be followed for 9 months with clinical evaluation, imaging, audiometric, listening effort and quality of life assessments. These evaluations will be carried out preoperatively and postoperatively at 3 months and 6 months post-activation of the cochlear implant.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

February 20, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

February 17, 2025

Status Verified

February 1, 2025

Enrollment Period

1.8 years

First QC Date

December 8, 2023

Last Update Submit

February 13, 2025

Conditions

Keywords

Cochlear implantManual insertionRobotic assistance insertionHearing understanding in noiseQuality of life

Outcome Measures

Primary Outcomes (1)

  • Auditory performance in noise with the cochlear implant

    Evolution of the intelligibility score (Variation of the percentage of words understood) for monosyllabic Lafon words presented at 60 dB SPL with a signal-to-noise ratio of 10 dB (SNR10) between the preoperative score and the score at 6 months post-implantation

    At 6 months post-implantation

Secondary Outcomes (12)

  • Hearing performance in noise after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes

    At 3 and 6 months post-implantation

  • Hearing performance in noise under ecological conditions after robotic cochlear implantation compared to conventional manual cochlear implantation

    At 3 and 6 months post-implantation

  • Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for words

    At 3 and 6 months post-implantation

  • Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes

    At 3 and 6 months post-implantation

  • The subjective benefit on tinnitus after robotic cochlear implantation compared to conventional manual cochlear implantation

    At 3 and 6 months post-implantation

  • +7 more secondary outcomes

Study Arms (2)

Experimental arm

EXPERIMENTAL

Patient having cochlear implantation surgery with RobOtol®.

Procedure: Surgery with RobOtol®

Control arm

OTHER

Patient having conventional manual cochlear implantation surgery.

Procedure: Conventional manual surgery

Interventions

Patient having cochlear implantation surgery with RobOtol®.

Experimental arm

Patient having conventional manual cochlear implantation surgery

Control arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient ≥ 18 years old
  • Patients with an indication for uni or bilateral, simultaneous or sequential cochlear implantation: severe to profound bilateral deafness with intelligibility ≤70% for Fournier dissyllabic words, in free field, at 60dB with adapted hearing aids.
  • Patient able to understand the information note and give written consent
  • Affiliation to a French social security system

You may not qualify if:

  • Patient who does not speak French
  • Etiologies of deafness known to be of bad prognosis (auditory neuropathy, congenital profound deafness, immediate post-meningitis profound deafness, vestibular schwannoma on the side of the ear to be implanted)
  • Impossibility of testing the effect of the cochlear implant alone on hearing results (cochlear implantation in the context of unilateral deafness or fluctuating deafness)
  • Cochlear implantation requiring the use of a perimodiolar electrode holder.
  • Pregnant and breastfeeding women
  • Patients wearing electronic devices, in direct connection with the brain or nervous system
  • Patient included in another interventional study (Jardé 1)
  • Patient under legal protection (guardianship or curatorship) or deprived of liberty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Pitié-Salpêtrière

Paris, 75013, France

RECRUITING

MeSH Terms

Interventions

Surgical Procedures, Operative

Study Officials

  • Ghizlene LAHLOU, Dr

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ghizlene LAHLOU, Dr

CONTACT

Isabelle MOSNIER, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2023

First Posted

February 8, 2024

Study Start

February 20, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

February 17, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

The procedures carried out with the French data privacy authority (CNIL, Commission nationale de l'informatique et des libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients. Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 3 months and ending 3 years following article publication. Requests out of these time frame can also be submitted to the sponsor
Access Criteria
Researchers who provide a methodologically sound proposal.

Locations